Hospitalization rates and 30-day all-cause mortality among head and neck cancer patients and survivors with COVID-19.

ABSTRACT:

Background

The impact of COVID-19 on patients with cancer is emerging, but data are urgently needed for head and neck cancer (HNC) patients or survivors who are inherently high-risk for severe illness and mortality with SARS-CoV-2 infection.

Methods

This multi-institution, academic cohort study collected comprehensive data on clinical risk factors, COVID-19 symptoms and viral testing patterns, information about hospitalization rates, and predictors of survival among HNC patients with active disease or in remission. The primary endpoint was 30-day all-cause mortality from the date of confirmed COVID-19. We performed multivariate analysis to understand the prognostic value of clinical and laboratory parameters on outcomes.

Results

Thirty-two patients with COVID-19 and H

SUBMITTER: Hanna GJ 

PROVIDER: S-EPMC7833708 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature